Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain

  • Vilaprinyo, Ester
  • Puig Reixach, Maria Teresa|||0000-0003-1402-7653
  • Rué, Montserrat|||0000-0002-7862-9365
Background: Reductions in breast cancer (BC) mortality in Western countries have been attributed to the use of screening mammography and adjuvant treatments. The goal of this work was to analyze the contributions of both interventions to the decrease in BC mortality between 1975 and 2008 in Catalonia. Methodology/Principal Findings: A stochastic model was used to quantify the contribution of each intervention. Age standardized BC mortality rates for calendar years 1975-2008 were estimated in four hypothetical scenarios: 1) Only screening, 2) Only adjuvant treatment, 3) Both interventions, and 4) No intervention. For the 30-69 age group, observed Catalan BC mortality rates per 100,000 women-year rose from 29.4 in 1975 to 38.3 in 1993, and afterwards continuously decreased to 23.2 in 2008. If neither of the two interventions had been used, in 2008 the estimated BC mortality would have been 43.5, which, compared to the observed BC mortality rate, indicates a 46.7% reduction. In 2008 the reduction attributable to screening was 20.4%, to adjuvant treatments was 15.8% and to both interventions 34.1%. Conclusions/Significance: Screening and adjuvant treatments similarly contributed to reducing BC mortality in Catalonia. Mathematical models have been useful to assess the impact of interventions addressed to reduce BC mortality that occurred over nearly the same periods. © 2012 Vilaprinyo et al.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Treatment of Dyspareunia with Botulinum Neurotoxin Type A: Clinical Improvement and Influence of Patients&apos, Characteristics

  • Tarazona-Motes, Marta
  • Albaladejo-Belmonte, Mónica
  • Nohales-Alfonso, Francisco J.
  • De-Arriba, Maria
  • Alberola-Rubio, Jose
  • Garcia-Casado, Javier|||0000-0003-1410-2721
[EN] The treatment of chronic pelvic pain (CPP) with botulinum neurotoxin type A (BoNT/A) has increased lately, but more studies assessing its effect are needed. This study aimed to evaluate the evolution of patients after BoNT/A infiltration and identify potential responders to treatment. Twenty-four women with CPP associated with dyspareunia were treated with 90 units of BoNT/A injected into their pelvic floor muscle (PFM). Clinical status and PFM activity were monitored in a previous visit (PV) and 12 and 24 weeks after the infiltration (W12, W24) by validated clinical questionnaires and surface electromyography (sEMG). The influence of patients' characteristics on the reduction in pain at W12 and W24 was also assessed. After treatment, pain scores and the impact of symptoms on quality of life dropped significantly, sexual function improved and sEMG signal amplitude decreased on both sides of the PFM with no adverse events. Headaches and bilateral pelvic pain were risk factors for a smaller pain improvement at W24, while lower back pain was a protective factor. Apart from reporting a significant clinical improvement of patients with CPP associated with dyspareunia after BoNT/A infiltration, this study shows that clinical characteristics should be analyzed in detail to identify potential responders to treatment., This study was funded by Universitat Politecnica de Valencia in Programa de Ayudas de Investigacion y Desarrollo (PAID-01-20), ISCIII, MCIU, VLC Campus in Convocatoria Ayudas: UPV-La Fe (INBIO): 2016 SPEHG (ID:C18), 2019 sEMG_BONTAv (ID:C06) and funds from private contracts with Merz Pharmaceuticals GmbH S.L.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Contribución de congreso (ConferenceOutput)

Influence of voluntary contractions on the basal sEMG activity of the pelvic floor muscles

  • Albaladejo-Belmonte, Monica
  • Tarazona-Motes, Marta
  • Nohales-Alfonso, Francisco J.
  • Alberola-Rubio, Jose
  • Garcia-Casado, Javier|||0000-0003-1410-2721
[EN] Chronic pelvic pain (CPP) is a complex clinical condition that affects many women, being sometimes misdiagnosed or mistreated,which can be treated with the infiltration of botulinum toxin (BoNTA). The pelvic floor musculature (PFM) condition from CPP patients can be assessed by means of surface electromyography (sEMG). The evaluation of the basal activity can help to detect a muscular dysfunction, therefore it is important to ensure that the PFM shows a minimum activation when its sEMG is being analysed. In this study, we recorded the sEMG of 25 women with CPP before and 8, 12 and 24 weeks after their treatment with BoNTA while they performed a protocol of 5 voluntary contractions. The root mean square (RMS) and sample entropy (SampEn) of basal segments pre- (B[PRE]), inter- (B[I]) and post- (B[POST]) contractions of the sEMG were computed and normalized according to the minimum (RMSnorm) and maximum (SampEnorm) of the recording. B(PRE) showed the lowest RMSnorm median both before and after the treatment with BoNTA, which proved that the activity of the PFM is minimum before the first contraction. As for SampEnnorm, although results were not so conclusive, they also indicated that B(PRE) should be taken as a reference to analyse the PFM function at its state of minimum activity. Future works aiming to characterize the effects of BoNTA in PFM by means of sEMG should consider basal segments before contractions to assess basal tone conditions., This study was funded by ISCIII, MCIU, VLC Campus in Convocatoria Ayudas: UPV-La Fe (INBIO): 2016 SPEHG (ID:C18), 2019 sEMG_BONTAv (ID:C06) and with funds from private contracts with Merz Pharma España S.L.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer

  • Sanmartín, Elena
  • Usó, Marta
  • Blasco, Ana
  • Gallach, Sandra
  • Figueroa, Santiago
  • Martínez, Nieves
  • Hernando, Cristina
  • Honguero, Antonio
  • Martorell, Miguel
  • Guijarro, Ricardo
  • Rosell, Rafael
  • Jantus-Lewintre, Eloisa
  • Camps, Carlos
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
[EN] Background. Angiogenesis and lymphangiogenesis are key mechanisms for tumor growth and dissemination. They are mainly regulated by the vascular endothelial growth factor (VEGF) family of ligands and receptors. The aim of this study was to analyze relative expression levels of angiogenic markers in resectable non-small cell lung cancer patients in order to asses a prognostic signature that could improve characterization of patients with worse clinical outcomes. Methods. RNA was obtained from tumor and normal lung specimens from 175 patients. Quantitative polymerase chain reaction was performed to analyze the relative expression of HIF1A, PlGF, VEGFA, VEGFA(165b), VEGFB, VEGFC, VEGFD, VEGFR1, VEGFR2, VEGFR3, NRP1 and NRP2. Results. Univariate analysis showed that tumor size and ECOG-PS are prognostic factors for time to progression (TTP) and overall survival (OS). This analysis in the case of angiogenic factors also revealed that PlGF, VEGFA, VEGFB and VEGFD distinguish patients with different outcomes. Taking into account the complex interplay between the different ligands of the VEGF family and to more precisely predict the outcome of the patients, we considered a new analysis combining several VEGF ligands. In order to find independent prognostic variables, we performed a multivariate Cox analysis, which showed that the subgroup of patients with higher relative expression of VEGFA plus lower VEGFB and VEGFD presented the poorest outcome for both TTP and OS. Conclusions. The relative expression of these three genes can be considered as an angiogenic gene signature whose applicability for the selection of candidates for targeted therapies needs to be further validated., This study was partially supported by a grant from the Instituto de Salud Carlos III (FIS PI06/1041 and PS09/1149), Red Tematica de Investigacion Cooperativa en Cancer (RD06/0020/1024), and FEDER.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC

  • Jantus-Lewintre, Eloisa|||0000-0001-7395-4380
  • Sirera Pérez, Rafael|||0000-0001-9162-8490
  • Sanmartin, Elena
  • Blasco, Ana
  • Sanchez, Jose Javier
  • Taron, Miguel
  • Rosell, Rafael
  • Camps, Carlos
Introduction: The vascular endothelial growth factor (VEGF) family of ligands and receptors (VEGFR) play an important role in tumor angiogenesis. Increased expression of angiogenic factors in tumors or in blood is associated with poor prognosis. The aim of this study was to investigate the role of VEGF-A and soluble VEGFR-2 (sVEGFR-2) as biomarkers in advanced non-small-cell lung cancer (NSCLC). Methods: We studied 432 patients with advanced NSCLC (stages IIIB-IV) treated with cisplatin and docetaxel and 89 healthy age-matched controls. Blood samples were collected before chemotherapy, and VEGF-A and sVEGFR-2 levels were determined by ELISA. Results: VEGF-A and sVEGFR-2 levels were higher in NSCLC patients than in the controls, but VEGF-A behaves as a better diagnostic biomarker. There were no significant associations between VEGF-A and sVEGFR-2 concentrations and clinical characteristics, such as ECOG-PS, gender, stage, histology, metastases, and treatment response. A patient subgroup characterized by a combination of high VEGF-A and low sVEGFR-2 levels exhibited the worst patient prognoses in terms of TTP and OS. Conclusions: VEGF-A and sVEGFR-2 levels were significantly higher in patients than in the controls. A combination of VEGF-A and sVEGFR-2 can be used as an independent prognostic biomarker in advanced NSCLC. © 2011 Elsevier Ireland Ltd., This work was supported in part, by a grant [PI06/104] from Instituto de Salud Carlos III and a grant [RD06/0020/1024] from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation and European Regional Development Fund (ERDF) "Una manera de hacer Europa".
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Validation of DM-Scan, a computer-assisted tool to assess mammographic density in full-field digital mammograms

  • Pollán, Marina
  • Miranda García, Josefa
  • Antón Guirao, Joaquín
  • Casals el Busto, María
  • Martinez Gomez, Inmaculada
  • Palop Jonquères, Carmen
  • Ruiz Perales, Francisco
  • Sanchez Contador, Carmen
  • Vidal, Carmen
  • Perez Gómez, Beatriz
  • Salas Trejo, Dolores
  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
We developed a semi-automated tool to assess mammographic density (MD), a phenotype risk marker for breast cancer (BC), in full-field digital images and evaluated its performance testing its reproducibility, comparing our MD estimates with those obtained by visual inspection and using Cumulus, verifying their association with factors that influence MD, and studying the association between MD measures and subsequent BC risk. Three radiologists assessed MD using DM-Scan, the new tool, on 655 processed images (craniocaudal view) obtained in two screening centers. Reproducibility was explored computing pair-wise concordance correlation coefficients (CCC). The agreement between DM-Scan estimates and visual assessment (semi- uantitative scale, 6 categories) was quantified computing weighted kappa statistics (quadratic weights). DM-Scan and Cumulus readings were compared using CCC. Variation of DM-Scan measures by age, body mass index (BMI) and other MD modifiers was tested in regression mixed models with mammographic device as a random-effect term. The association between DM-Scan measures and subsequent BC was estimated in a case control study. All BC cases in screening attendants (2007 2010) at a center with full-field digital mammography were matched by age and screening year with healthy controls (127 pairs). DM-Scan was used to blindly assess MD in available mammograms (112 cases/119 controls). Unconditional logistic models were fitted, including age, menopausal status and BMI as confounders. DM-Scan estimates were very reliable (pairwise CCC: 0.921, 0.928 and 0.916). They showed a reasonable agreement with visual MD assessment (weighted kappa ranging 0.79-0.81). DM-Scan and Cumulus measures were highly concordant (CCC ranging 0.80-0.84), but ours tended to be higher (4%-5% on average). As expected, DM-Scan estimates varied with age, BMI, parity and family history of BC. Finally, DM-Scan measures were significantly associated with BC (p-trend=0.005). Taking MD<7% as reference, OR per categories of MD were: OR7%-17%=1.32 (95% CI=0.59-2.99), OR17%-28%=2.28 (95% CI=1.03-5.04) and OR>=29%=3.10 (95% CI=1.35-7.14). Our results confirm that DM-Scan is a reliable tool to assess MD in full-field digital mammograms., This work was supported by research grants from Spain's Health Research Fund (Fondo de INvestigacion Santiaria) (PI060386 & PI09/1230); Gent per Gent Fund (EDEMAC Project) and the Spanish Federation of Breast Cancer Patients (Federacion Espanola de Cancer de Mama) (FECMA 485 EPY 1170-10).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Semi-automated and fully automated mammographic density measurement and breast cancer risk prediction

  • Llobet Azpitarte, Rafael|||0000-0002-8278-9740
  • Pollán, Marina
  • Antón Guirao, Joaquín
  • Miranda-García, Josefa
  • Casals el Busto, María
  • Martinez Gomez, Inmaculada
  • Ruiz Perales, Francisco
  • Pérez Gómez, Beatriz
  • Salas-Trejo, Dolores
  • Perez-Cortes, Juan-Carlos
The task of breast density quantification is becoming increasingly relevant due to its association with breast cancer risk. In this work, a semi-automated and a fully automated tools to assess breast density from full-field digitized mammograms are presented. The first tool is based on a supervised interactive thresholding procedure for segmenting dense from fatty tissue and is used with a twofold goal: for assessing mammographic density(MD) in a more objective and accurate way than via visual-based methods and for labeling the mammograms that are later employed to train the fully automated tool. Although most automated methods rely on supervised approaches based on a global labeling of the mammogram, the proposed method relies on pixel-level labeling, allowing better tissue classification and density measurement on a continuous scale. The fully automated method presented combines a classification scheme based on local features and thresholding operations that improve the performance of the classifier. A dataset of 655 mammograms was used to test the concordance of both approaches in measuring MD. Three expert radiologists measured MD in each of the mammograms using the semi-automated tool (DM-Scan). It was then measured by the fully automated system and the correlation between both methods was computed. The relation between MD and breast cancer was then analyzed using a case-control dataset consisting of 230 mammograms. The Intraclass Correlation Coefficient (ICC) was used to compute reliability among raters and between techniques. The results obtained showed an average ICC = 0.922 among raters when using the semi-automated tool, whilst the average correlation between the semi-automated and automated measures was ICC = 0.838. In the case-control study, the results obtained showed Odds Ratios (OR) of 1.38 and 1.50 per 10% increase in MD when using the semi-automated and fully automated approaches respectively. It can therefore be concluded that the automated and semi-automated MD assessments present a good correlation. Both the methods also found an association between MD and breast cancer risk, which warrants the proposed tools for breast cancer risk prediction and clinical decision making. A full version of the DM-Scan is freely available. (C) 2014 Elsevier Ireland Ltd. All rights reserved., This work was supported by research grants from Gent per Gent Fund (EDEMAC Project); Spain's Health Research Fund (Fondo de Investigacion Santiaria) (PI060386 & FIS PS09/00790); Spanish MICINN grants TIN2009-14205-C04-02 and Consolider-Ingenio 2010: MIPRCV (CSD2007-00018); Spanish Federation of Breast Cancer Patients (Federacion Espanola de Cancer de Mama) (FECMA 485 EPY 1170-10). The English revision of this paper was funded by the Universitat Politecnica de Valencia, Spain.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers

  • López-Mejías, Raquel
  • Castañeda, Santos
  • González-Juanatey, Carlos
  • Corrales, Alfonso
  • Ferraz-Amaro, Iván
  • Genre, Fernanda
  • Rodríguez-Rodríguez, Luis
  • Blanco, Ricardo
  • Llorca, Javier
  • Martín, J.
  • González-Gay, Miguel A.
Cardiovascular disease (CV) is the most common cause of premature mortality in patients with rheumatoid arthritis (RA). This is the result of an accelerated atherosclerotic process. Adequate CV risk stratification has special relevance in RA to identify patients at risk of CV disease. However, current CV risk screening and management strategies underestimate the actual CV risk in RA. Consequently, the search for additional tools that may help to identify those patients at high CV risk has become a key objective in the last years. In this regard, non-invasive surrogates, such as carotid ultrasonography, have been found to be excellent predictors of future CV events. In addition, several studies have revealed the relevance of a genetic component in the development of CV disease in RA patients. Besides an association with HLA-DRB1* shared epitope alleles other gene polymor-phisms located inside and outside the HLA seem to influence the risk of cardiovascular disease in RA. Moreover, serum levels of some metabolic syndrome-related biomarkers, adipokines such as adiponectin and biomarkers of endothelial cell activation and inflammation such as Osteoprotegerin and Asymmetric dimethylarginine have recently been found useful for the prediction of CV disease in these patients. An update of the current knowledge on these potential markers, especially focused on new genetic and serological biomarkers is shown in this review. (C) 2016 The Authors. Published by Elsevier B.V., This work was supported by European Union FEDER funds and "Fondo de Investigation Sanitaria" (grants PI06/0024, PS09/00748, PI12/00060 and PI15/00525) from 'Institut de Salud Carlos III' (ISCIII, Health Ministry, Spain). It was also partially supported by RETICS Programs RD12/0009 (RIER) from 'Instituto de Salud Carlos III' (ISCIII, Health Ministry, Spain), and in part by grants from the European IMI BTCure Program. We wish to specially thank Mercedes Garcia-Bermudez, Begona Ubilla, Veronica Mijares, Patricia Fuentevilla Rodriguez, Virginia Portilla Gonzalez and all the clinicians from Spanish National Health Care system that have been involved in our studies., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Prevalence of and factors associated with homebound status among adults in urban and rural Spanish populations

  • Negrón-Blanco, L.
  • De Pedro-Cuesta, J.
  • Almazán, J.
  • Rodríguez-Blázquez, C.
  • Franco, E.
  • Damián, J.
Background: There is a marked growth in the number of homebound older adults, due mainly to increased life expectancy. Although this group has special characteristics and needs, it has not been properly studied. This study thus aimed to measure the prevalence of homebound status in a community-dwelling population, and its association with both socio-demographic, medical and functional characteristics and the use of health care and social services.Methods: We used instruments coming under the WHO International Classification of Functioning (ICF) framework to carry out a cross-sectional study on populations aged 50 years and over in the province of Zaragoza (Spain), covering a total of 1622 participants. Persons who reported severe or extreme difficulty in getting out of the house in the last 30 days were deemed to be homebound. We studied associations between homebound status and several relevant variables in a group of 790 subjects who tested positive to the WHODAS-12 disability screening tool.Results: Prevalence of homebound status was 9.8 % (95 % CI: 8.4 to 11.3 %). Homebound participants tended to be older, female and display a lower educational level, a higher number of diseases, poorer cognition and a higher degree of disability. In fully adjusted models including disability as measured with the ICF-Checklist, the associated variables (odds ratios and [95 % confidence intervals]) were: female gender (3.75 [2.10–6.68]); urban population (2.36 [1.30–4.29]); WHODAS-12 disability (6.27 [2.56–15.40]); depressive symptoms (2.95 [1.86–4.68]); moderate pain (2.37 [1.30–4.31] and severe pain (3.03 [1.31–7.01]), as compared to the group with no/mild pain; hospital admissions in the previous 3 months (2.98 [1.25–7.11]); and diabetes (1.87 [1.03–3.41]). Adjustment for ICF-Checklist disability had a notable impact on most associations.Conclusions; The study shows that homebound status is a common problem in our setting, and that being disabled is its main determinant. Socio-demographic characteristics, barriers and chronic diseases can also be assumed to be playing a role in the onset of this condition, indicating the need for further research, including longitudinal studies on its incidence and associated factors.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Disability, support and long-term social care of an elderly Spanish population, 2008-2009: An epidemiologic analysis

  • Almazán-Isla, J.
  • Comín-Comín, M.
  • Alcalde-Cabero, E.
  • Ruiz, C.
  • Franco, E.
  • Magallón, R.
  • Damián, J.
  • De Pedro-Cuesta, J.
  • Larrosa-Montañes, L.A.
Background: Though poorly known, relationships between disability, need of help (dependency) and use of social services are crucial aspects of public health. The objective of this study was to describe the links between disability, officially assessed dependency, and social service use by an industrial population, and identify areas of inequity. Methods: We took advantage of a door-to-door survey conducted in the Cinco Villas district, Spain, in 2008-2009, which provided data on disability, morbidity, and service use among 1216 residents aged =50 years, and officially assessed dependency under the 2006 Dependency Act (OAD). Using logistic regression, we combined data collected at homes/residences on 625 disability screened-positive participants, and administrative information on degree of OAD and benefits at date of visit. Results: Based on 163 disabled persons, the prevalence of residential/community-care users was 13.4% overall, with 6.0% being market-provided, 2.5% supported by the 2006 Act, and 4.9% supported by other public funds. Of 111 OAD applicants, 30 had been assigned an OAD degree; in 29 cases this was the highest OAD degree, with 12 receiving direct support for residential care and 17 receiving home care. Compared to unassessed dependency, the highest OAD degree was linked to residential care (OR and 95% CI) 12.13 (3.86-38.16), declared non-professional care 10.99 (1.28-94.53), and publicly-funded, non-professional care 26.30 (3.36-205.88). In contrast, 43 persons, 58% of the severely/extremely disabled, community-dwelling sample population, 81% of whom were homebound, including 10 persons with OAD but no implemented service plan, made no use of any service, and of these, 40% lacked a non-professional carer. Conclusions: Formal service use in the Cinco Villas district attained ratios observed for established welfare systems but the publicly-funded proportion was lower. The 2006 Act had a modest, albeit significant, impact on support for non-professional carers and residential care, coexisting with a high prevalence of non-use of social services by severely disabled persons.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Physical activity, body functions and disability among middle-aged and older Spanish adults

  • Caron, Alexandre
  • Ayala, Alba
  • Damián, Javier
  • Rodriguez-Blazquez, Carmen
  • Almazán, Javier
  • Castellote, Juan Manuel
  • Comin, Magdalena
  • Forjaz, Maria João
  • Pedro, Jesús de
Background: Physical activity (PA) is a health determinant among middle-aged and older adults. In contrast, poor health is expected to have a negative impact on PA. This study sought to assess to what extent specific International Classification of Functioning, Disability and Health (ICF) health components were associated with PA among older adults. Methods: We used a sample of 864 persons aged =50 years, positively screened for disability or cognition in a cross-sectional community survey in Spain. Weekly energy expenditure during PA was measured with the Yale Physical Activity Survey (YPAS) scale. The associations between body function impairment, health conditions or World Health Organization Disability Assessment Schedule (WHODAS 2.0) disability scores and energy expenditure were quantified using negative-binomial regression, and expressed in terms of adjusted mean ratios (aMRs). Results: Mean energy expenditure was 4542 Kcal/week. A lower weekly energy expenditure was associated with: severe/extreme impairment of mental functions, aMR 0.38, 95% confidence interval, CI (0.21-0.68), and neuromusculoskeletal and movement functions, aMR 0.50 (0.35-0.72); WHODAS 2.0 disability, aMR 0.55 (0.34-0.91); dementia, aMR 0.45 (0.31-0.66); and heart failure, aMR 0.54 (0.34-0.87). In contrast, people with arthritis/osteoarthritis had a higher energy expenditure, aMR 1.27 (1.07-1.51). Conclusion: Our results suggest that there is a strong relationship between selected body function impairments, mainly mental, and PA. Although more research is needed to fully understand causal relationships, strategies to improve PA among the elderly may require targeting mental, neuromusculoskeletal and movement functions, disability determinants (including barriers), and specific approaches for persons with dementia or heart failure.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Predicting the onset of anxiety syndromes at 12 months in primary care attendees. The predictA-Spain study

  • Moreno-Peral, P.
  • De Dios Luna, J.
  • Marston, L.
  • King, M.
  • Nazareth, I.
  • Motrico, E.
  • Gildegómez-Barragán, M. J.
  • Torres-González, F.
  • Montón-Franco, C.
  • Sánchez-Celaya, M.
  • Díaz-Barreiros, M. A.
  • Vicens, C.
  • Muñoz-Bravo, C.
  • Bellón, J. Á.
Background: There are no risk algorithms for the onset of anxiety syndromes at 12 months in primary care. We aimed to develop and validate internally a risk algorithm to predict the onset of anxiety syndromes at 12 months. Methods: A prospective cohort study with evaluations at baseline, 6 and 12 months. We measured 39 known risk factors and used multilevel logistic regression and inverse probability weighting to build the risk algorithm. Our main outcome was generalized anxiety, panic and other non-specific anxiety syndromes as measured by the Primary Care Evaluation of Mental Disorders, Patient Health Questionnaire (PRIME-MD-PHQ). We recruited 3, 564 adult primary care attendees without anxiety syndromes from 174 family physicians and 32 health centers in 6 Spanish provinces. Results: The cumulative 12-month incidence of anxiety syndromes was 12.2%. The predictA-Spain risk algorithm included the following predictors of anxiety syndromes: province; sex (female); younger age; taking medicines for anxiety, depression or stress; worse physical and mental quality of life (SF-12); dissatisfaction with paid and unpaid work; perception of financial strain; and the interactions sex*age, sex*perception of financial strain, and age*dissatisfaction with paid work. The C-index was 0.80 (95% confidence interval = 0.78-0.83) and the Hedges'' g = 1.17 (95% confidence interval = 1.04-1.29). The Copas shrinkage factor was 0.98 and calibration plots showed an accurate goodness of fit. Conclusions: The predictA-Spain risk algorithm is valid to predict anxiety syndromes at 12 months. Although external validation is required, the predictA-Spain is available for use as a predictive tool in the prevention of anxiety syndromes in primary care.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Disparity between capacity and performance in the International Classification of Functioning: implications for functionality in older adults

  • Ruiz-Garrós, María Cristina
  • Laborda Soriano, Ana Alejandra
  • Cambra-Aliaga, Alba
  • Dominguez-Oliván, Pilar
  • Perez-de-Heredia-Torres, Marta
  • Gonzalo-Ciria, Laura
  • Gascón-Catalán, Ana
Background Functioning, recognized as the third health indicator and a key metric for rehabilitation, can be assessed by measuring capacity and performance. Objective To quantify the prevalence of disability and cognitive impairment in individuals aged 50+ and evaluate the reliability and clinical relevance of capacity and performance qualifiers in the activity and participation domains of the international classification of functioning checklist (ICF checklist). Methods A cross-sectional study was conducted in a population from rural and urban areas of Aragón (Spain), including 1707 participants. Disability and cognitive impairment were assessed using the WHO Disability Assessment Schedule 12-item version (WHODAS 12) and mini-mental state examination. A randomly selected subsample (n = 129) underwent a detailed functional evaluation. The ICF checklist was used to compare capacity and performance, analyzing their agreement and differences. Results Disability was present in 50.6% of participants. Severe or total disability was most prevalent in general tasks/demands (10.1%) and domestic life (7.1%), reflecting significant daily functioning limitations. The largest capacity-performance discrepancies were in domestic life, self-care, and learning, indicating key intervention areas. Notably, 40.5% of participants had lower performance in domestic life, followed by learning/knowledge (28%) and mobility (17%). Conversely, performance exceeded capacity in community living (13.3%) and personal relationships (5.5%), highlighting the influence of environmental factors. Conclusions Disability is highly prevalent in adults aged 50+, notably affecting daily functioning. Gaps between ability and performance indicate environmental barriers, especially at home and in learning contexts. Improved outcomes in social domains suggest enabling conditions. Findings support the ICF checklist's clinical value and advocate for integrating environmental factors into disability care.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

  • Gallardo, Alberto|||0000-0002-2514-2027
  • Lerma Puertas, Enrique|||0000-0001-7908-2747
  • Escuin i Borràs, Daniel|||0000-0003-3538-0579
  • Tibau Martorell, Ariadna|||0000-0003-0229-6987
  • Muñoz, J.
  • Ojeda, Belén
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
  • Adrover, Encarna|||0000-0001-8676-8560
  • Sánchez-Tejada, Laura
  • Giner, D.
  • Ortiz-Martínez, Fernando
  • Peiró, Gloria|||0000-0002-2899-2908
Trastuzumab resistance hampers its well-known efficacy to control HER2-positive breast cancer. The involvement of PI3K/Akt pathway in this mechanism is still not definitively confirmed. We selected 155 patients treated with trastuzumab after development of metastasis or as adjuvant/neoadjuvant therapy. We performed immunohistochemistry for HER2, ER/PR, epidermal growth factor 1-receptor (EGFR), α -insulin-like growth factor 1-receptor (IGF1R), phosphatase and tensin homologue (PTEN), p110 α, pAkt, pBad, pmTOR, pMAPK, MUC1, Ki67, p53 and p27; mutational analysis of PIK3CA and PTEN, and PTEN promoter hypermethylation. We found 46% ER/PR-positive tumours, overexpression of EGFR (15%), α -IGF1R (25%), p110 α (19%), pAkt (28%), pBad (22%), pmTOR (23%), pMAPK (24%), MUC1 (80%), PTEN loss (20%), and PTEN promoter hypermethylation (20%). PIK3CA and PTEN mutations were detected in 17% and 26% tumours, respectively. Patients receiving adjuvant trastuzumab with α -IGF1R or pBad overexpressing tumours presented shorter progression-free survival (PFS) (all P ⩽0.043). Also, p110 α and mTOR overexpression, liver and brain relapses implied poor overall survival (OS) (all P ⩽0.041). In patients with metastatic disease, decreased PFS correlated with p110 α expression (P =0.024), whereas for OS were the presence of vascular invasion and EGFR expression (P ⩽0.019; Cox analysis). Our results support that trastuzumab resistance mechanisms are related with deregulation of PTEN/PI3K/Akt/mTOR pathway, and/or EGFR and IGF1R overexpression in a subset of HER2-positive breast carcinomas.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Family caregiver mistreatment of the elderly, prevalence of risk and associated factors

  • Orfila, Francesc|||0000-0002-2409-1731
  • Coma-Solé, Montserrat
  • Cabanas, Marta
  • Cegri-Lombardo, Francisco
  • Moleras-Serra, Anna|||0000-0001-9927-6899
  • Pujol Ribera, Enriqueta|||0000-0002-9475-0755
The detection of elder mistreatment is emerging as a public health priority; however, abusive behaviors exercised by caregivers are little known and rarely detected among primary health care professionals. This study aims to estimate the prevalence of risk of abuse against community-residing elderly with moderate to severe dependency whose caregivers are relatives. In addition, we aim to describe the association between such a risk and socio-demographic variables, cognitive and dependency state of the victim, and the scale of the caregiver's anxiety, depression, and burden. Cross-sectional study developed in 72 Primary Health Care teams from Barcelona, Spain. Participants were caregivers and their dependent care recipients (N = 829). Home interviews included the Caregiver Abuse Screen (CASE); self-reported abuse from care recipient; activities of daily living and cognitive state of the care recipient; anxiety and depression in caregivers and Caregiver Burden Scale. The relationship prior to the dependency, positive aspects of caregiving, and social support for the caregiver were also assessed. Multivariate analysis was performed using logistic regression with risk of abuse as dependent variable. Caregivers were mainly women (82.8%) with a mean age of 63.3 years. Caregivers and care recipients lived in the same household in 87.4% of cases, and 86.6% had enjoyed a good previous relationship. Care recipients were women (65.6%), with a mean age of 84.2 years, and 64.2% had moderate to severe cognitive impairment. CASE demonstrated a prevalence of 33.4% (95% CI: 30.3-36.7) of abuse risk by the caregiver. Logistic regression showed as statistically significant: caregiver burden (OR = 2.75; 95% CI: 1.74-4.33), caregiver anxiety (OR = 2.06; 95% CI: 1.40-3.02), caregiver perception of aggressive behavior in the care recipient (OR = 7.24; 95% CI: 4.99-10.51), and a bad previous relationship (OR = 4.66; 95% CI: 1.25-17.4). Prevalence of risk of abuse is high among family caregivers. Our study has found risk factors in family caregivers that are preventable to an extent, namely: anxiety and feelings of burden. It is essential to become aware of these risk factors and their causes to intervene and help primary as well secondary prevention.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Subtypes of patients experiencing exacerbations of COPD and associations with outcomes

  • Arostegui, Inmaculada|||0000-0002-6848-2240
  • Esteban, Cristóbal
  • Garcia Gutierrez, Susana|||0000-0002-8474-2479
  • Baré i Mañas, Marisa|||0000-0001-8085-2833
  • Fernández de Larrea, Nerea
  • Briones, Eduardo
  • Quintana López, José María|||0000-0003-2170-7876
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous condition characterized by occasional exacerbations. Identifying clinical subtypes among patients experiencing COPD exacerbations (ECOPD) could help better understand the pathophysiologic mechanisms involved in exacerbations, establish different strategies of treatment, and improve the process of care and patient prognosis. The objective of this study was to identify subtypes of ECOPD patients attending emergency departments using clinical variables and to validate the results using several outcomes. We evaluated data collected as part of the IRYSS-COPD prospective cohort study conducted in 16 hospitals in Spain. Variables collected from ECOPD patients attending one of the emergency departments included arterial blood gases, presence of comorbidities, previous COPD treatment, baseline severity of COPD, and previous hospitalizations for ECOPD. Patient subtypes were identified by combining results from multiple correspondence analysis and cluster analysis. Results were validated using key outcomes of ECOPD evolution. Four ECOPD subtypes were identified based on the severity of the current exacerbation and general health status (largely a function of comorbidities): subtype A (n = 934), neither high comorbidity nor severe exacerbation; subtype B (n = 682), moderate comorbidities; subtype C (n = 562), severe comorbidities related to mortality; and subtype D (n = 309), very severe process of exacerbation, significantly related to mortality and admission to an intensive care unit. Subtype D experienced the highest rate of mortality, admission to an intensive care unit and need for noninvasive mechanical ventilation, followed by subtype C. Subtypes A and B were primarily related to other serious complications. Hospitalization rate was more than 50% for all the subtypes, although significantly higher for subtypes C and D than for subtypes A and B. These results could help identify characteristics to categorize ECOPD patients for more appropriate care, and help test interventions and treatments in subgroups with poor evolution and outcomes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Heroin-dependent patient satisfaction with methadone as a medication influences satisfaction with basic interventions delivered by staff to implement methadone maintenance treatment

  • Alcaraz Garcia, Saül|||0000-0002-5720-8801
  • Viladrich, Carme|||0000-0002-7464-1455
  • Trujols, Joan|||0000-0003-0396-7105
  • Siñol, Núria
  • Pérez de los Cobos, José|||0000-0002-9796-5823
The aim of the present study was to test a structural equation model of patient satisfaction with different key facets of methadone maintenance treatment (MMT). In this model, the three dimensions of patient satisfaction with methadone as a medication (ie, personal functioning and well-being, anti-addictive effect on heroin, and anti-addictive effect on non-opioid substances) were expected to predict satisfaction with the basic interventions delivered by the staff of treatment centers to implement MMT. A sample of 210 heroin-dependent patients, resistant to MMT treatment (mean age =41.66 years, SD =6.50; 75.7% male), participated voluntarily in this study. Preliminary analysis based on exploratory structural equation modeling supported the expected three-factor measurement model of the scale to assess satisfaction with medications for addiction treatment - methadone for heroin addiction. Moreover, the 15 items measuring staff's basic interventions were shown to be compatible with the expected single-factor measurement model. Then, both measurement models were included in a structural model. Results of this model show that patient satisfaction with the compatibility of methadone with personal functioning and well-being, as well as with the anti-addictive effects of methadone on non-opioid substances, predicts satisfaction with basic interventions conducted at methadone treatment centers (β=0.191 and β=0.152, respectively). Our results provide further understanding regarding patient satisfaction with MMT, which could help professionals to better understand patient perspective and experience during MMT. Funding for this study was provided by grants.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

  • López de Maturana, Evangelina
  • Rodríguez, Juan Antonio
  • Alonso, Lola|||0000-0002-3493-718X
  • Lao, Oscar
  • Molina Montes, Esther|||0000-0002-0428-2426
  • Martín-Antoniano, Isabel Adoración
  • Gómez-Rubio, Paulina
  • Lawlor, Rita
  • Carrato, Alfredo|||0000-0001-7749-8140
  • Hidalgo, Manuel|||0000-0002-3765-3318
  • Iglesias, Mar|||0000-0002-2274-4671
  • Molero, Xavier|||0000-0003-2473-7405
  • Löhr, Matthias
  • Michalski, Christopher
  • Perea, José
  • O'Rorke, Michael
  • Barberà, Victor Manuel
  • Tardón, Adonina|||0000-0001-5150-1209
  • Farré, Antoni|||0000-0003-1279-8868
  • Muñoz-Bellvis, Luis|||0000-0002-7809-5201
  • Crnogorac-Jurcevic, Tanja
  • Domínguez-Muñoz, Enrique
  • Gress, Thomas
  • Greenhalf, William
  • Sharp, Linda
  • Arnes, Luís
  • Cecchini, Lluís|||0000-0002-8873-0969
  • Balsells Valls, Joaquim|||0000-0002-1202-4136
  • Costello, Eithne
  • Ilzarbe, Lucas|||0000-0003-1798-6876
  • Kleeff, Jörg
  • Kong, Bo
  • Márquez, Mirari
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • O'Driscoll, Damian
  • Scarpa, Aldo
  • Ye, Weimin
  • Yu, Jingru
  • García-Closas, Montserrat
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Rothman, Nathaniel
  • Silverman, Debra T.
  • Albanes, Demetrius
  • Arslan, Alan A.
  • Beane-Freeman, Laura
  • Bracci, Paige M.
  • Brennan, Paul
  • Bueno-de-Mesquita, Bas
  • Buring, Julie
  • Canzian, Federico|||0000-0002-4261-4583
  • Du, Margaret
  • Gallinger, Steven
  • Gaziano, J. Michael
  • Goodman, Phyllis J.
  • Gunter, Marc
  • LeMarchand, Loic
  • Li, Donghui
  • Neale, Rachael E.
  • Peters, Ulrike
  • Petersen, Gloria M.
  • Risch, Harvey A.
  • Sánchez Pérez, María José|||0000-0003-4817-0757
  • Shu, Xiao-Ou
  • Thornquist, Mark D.
  • Visvanathan, Kala
  • Zheng, Wei|||0000-0003-1226-070X
  • Chanock, Stephen|||0000-0002-2324-3393
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Wolpin, Brian M.
  • Stolzenberg-Solomon, Rachael Z.
  • Klein, Alison P.
  • Amundadottir, Laufey T.|||0000-0003-1859-8971
  • Marti-Renom, Marc A.|||0000-0002-0151-4279
  • Real, Francisco X.|||0000-0001-9501-498X
  • Malats, Núria|||0000-0003-2538-3784
Pancreatic cancer (PC) is a complex disease in which both non-genetic and genetic factors interplay. To date, 40 GWAS hits have been associated with PC risk in individuals of European descent, explaining 4.1% of the phenotypic variance. We complemented a new conventional PC GWAS (1D) with genome spatial autocorrelation analysis (2D) permitting to prioritize low frequency variants not detected by GWAS. These were further expanded via Hi-C map (3D) interactions to gain additional insight into the inherited basis of PC. In silico functional analysis of public genomic information allowed prioritization of potentially relevant candidate variants. We identified several new variants located in genes for which there is experimental evidence of their implication in the biology and function of pancreatic acinar cells. Among them is a novel independent variant in NR5A2 (rs3790840) with a meta-analysis p value = 5.91E-06 in 1D approach and a Local Moran's Index (LMI) = 7.76 in 2D approach. We also identified a multi-hit region in CASC8 -a lncRNA associated with pancreatic carcinogenesis-with a lowest p value = 6.91E-05. Importantly, two new PC loci were identified both by 2D and 3D approaches: SIAH3 (LMI = 18.24), CTRB2/BCAR1 (LMI = 6.03), in addition to a chromatin interacting region in XBP1 -a major regulator of the ER stress and unfolded protein responses in acinar cells-identified by 3D; all of them with a strong in silico functional support. This multi-step strategy, combined with an in-depth in silico functional analysis, offers a comprehensive approach to advance the study of PC genetic susceptibility and could be applied to other diseases. The online version contains supplementary material available at 10.1186/s13073-020-00816-4.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases, Results of the Cardiovascular in Rheumatology (Carma) Project

  • Valero-Jaimes, Jesús A.
  • López-González, Ruth
  • Martín-Martínez, María A.
  • García-Gómez, Carmen
  • Sánchez-Alonso, Fernando
  • Sánchez Costa, Jesús T.
  • González-Juanatey, Carlos|||0000-0002-4483-9778
  • Revuelta-Evrad, Eva
  • Diaz-Torne, Cesar|||0000-0001-6275-7699
  • Fernández-Espartero, Cruz
  • Pérez-García, Carolina|||0000-0002-6695-6406
  • Torrente-Segarra, Vicenç|||0000-0001-6597-3565
  • Sánchez-Nievas, Ginés
  • Pérez-Sandoval, Trinidad
  • Font-Ugalde, Pilar|||0000-0002-0811-9079
  • García Vivar, María Luz|||0000-0001-8822-9843
  • Aurrecoechea, Elena|||0000-0001-6789-7236
  • Maiz-Alonso, Olga
  • Valls-García, Ramón
  • Miranda-Filloy, José A.
  • Llorca, Javier|||0000-0001-8569-861X
  • Castañeda, Santos|||0000-0002-7748-853X
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
Objective: Since obesity has been associated with a higher inflammatory burden and worse response to therapy in patients with chronic inflammatory rheumatic diseases (CIRD), we aimed to confirm the potential association between body mass index (BMI) and disease activity in a large series of patients with CIRDs included in the Spanish CARdiovascular in rheuMAtology (CARMA) registry. Methods: Baseline data analysis of patients included from the CARMA project, a 10-year prospective study of patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA) attending outpatient rheumatology clinics from 67 Spanish hospitals. Obesity was defined when BMI (kg/m 2) was.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency

  • Fernández Cancio, Mónica|||0000-0003-1872-3488
  • Camats Tarruella, Núria|||0000-0002-4863-8201
  • Flück, Christa E.
  • Zalewski, Adam
  • Dick, Bernhard
  • Frey, Brigitte M.
  • Monné, Raquel
  • Torán, Núria
  • Audí, Laura
  • Pandey, Amit V.|||0000-0001-8331-5902
The CYP17A1 gene regulates sex steroid biosynthesis in humans through 17α-hydroxylase/17,20 lyase activities and is a target of anti-prostate cancer drug abiraterone. In a 46, XY patient with female external genitalia, together with a loss of function mutation S441P, we identified a novel missense mutation V366M at the catalytic center of CYP17A1 which preferentially impaired 17,20 lyase activity. Kinetic experiments with bacterially expressed proteins revealed that V366M mutant enzyme can bind and metabolize pregnenolone to 17OH-pregnenolone, but 17OH-pregnenolone binding and conversion to dehydroepiandrosterone (DHEA) was impaired, explaining the patient's steroid profile. Abiraterone could not bind and inhibit the 17α-hydroxylase activity of the CYP17A1-V366M mutant. Molecular dynamics (MD) simulations showed that V366M creates a "one-way valve" and suggests a mechanism for dual activities of human CYP17A1 where, after the conversion of pregnenolone to 17OH-pregnenolone, the product exits the active site and re-enters for conversion to dehydroepiandrosterone. The V366M mutant also explained the effectiveness of the anti-prostate cancer drug abiraterone as a potent inhibitor of CYP17A1 by binding tightly at the active site in the WT enzyme. The V366M is the first human mutation to be described at the active site of CYP17A1 that causes isolated 17,20 lyase deficiency. Knowledge about the specificity of CYP17A1 activities is of importance for the development of treatments for polycystic ovary syndrome and inhibitors for prostate cancer therapy.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Ancient Haplotypes at the 15q24.2 Microdeletion Region Are Linked to Brain Expression of MAN2C1 and Children's Intelligence

  • Cáceres, Alejandro|||0000-0001-8551-6695
  • Esko, Tõnu
  • Pappa, Irene
  • Gutiérrez, Armand
  • Lopez-Espinosa, Maria-Jose
  • Llop, Sabrina
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Tiemeier, Henning|||0000-0002-4395-1397
  • Metspalu, Andres|||0000-0002-3718-796X
  • Joshi, Peter K.|||0000-0002-6361-5059
  • Wilsonx, James F.
  • Reina-Castillón, Judith
  • Shin, Jean|||0000-0001-7353-5178
  • Pausova, Zdenka
  • Paus, Tomáš
  • Sunyer, Jordi
  • Pérez-Jurado, Luis Alberto|||0000-0002-1988-3005
  • González, Juan R.|||0000-0003-3267-2146
The chromosome bands 15q24.1-15q24.3 contain a complex region with numerous segmental duplications that predispose to regional microduplications and microdeletions, both of which have been linked to intellectual disability, speech delay and autistic features. The region may also harbour common inversion polymorphisms whose functional and phenotypic manifestations are unknown. Using single nucleotide polymorphism (SNP) data, we detected four large contiguous haplotype-genotypes at 15q24 with Mendelian inheritance in 2,562 trios, African origin, high population stratification and reduced recombination rates. Although the haplotype-genotypes have been most likely generated by decreased or absent recombination among them, we could not confirm that they were the product of inversion polymorphisms in the region. One of the blocks was composed of three haplotype-genotypes (N1a, N1b and N2), which significantly correlated with intelligence quotient (IQ) in 2,735 children of European ancestry from three independent population cohorts. Homozygosity for N2 was associated with lower verbal IQ (2.4-point loss, p-value = 0.01), while homozygosity for N1b was associated with 3.2-point loss in non-verbal IQ (p-value = 0.0006). The three alleles strongly correlated with expression levels of MAN2C1 and SNUPN in blood and brain. Homozygosity for N2 correlated with over-expression of MAN2C1 over many brain areas but the occipital cortex where N1b homozygous highly under-expressed. Our population-based analyses suggest that MAN2C1 may contribute to the verbal difficulties observed in microduplications and to the intellectual disability of microdeletion syndromes, whose characteristic dosage increment and removal may affect different brain areas.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comparison of Dysferlin Expression in Human Skeletal Muscle with That in Monocytes for the Diagnosis of Dysferlin Myopathy

  • Gallardo, Eduard|||0000-0002-3942-3436
  • Luna Salva, Noemí de|||0000-0002-4342-794X
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Rojas-Garcia, Ricard|||0000-0003-1411-5573
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Flix, Bàrbara|||0000-0002-4731-7801
  • de Morrée, Antoine
  • van der Maarel, Silvère
  • Illa, Isabel|||0000-0002-2186-2684
Dysferlinopathies are caused by mutations in the dysferlin gene (DYSF). Diagnosis is complex due to the high clinical variability of the disease and because dysferlin expression in the muscle biopsy may be secondarily reduced due to a primary defect in some other gene. Dysferlin is also expressed in peripheral blood monocytes (PBM). Studying dysferlin in monocytes is used for the diagnosis of dysferlin myopathies. The aim of the study was to determine whether dysferlin expression in PBM correlates with that in skeletal muscle. Using western-blot (WB) we quantified dysferlin expression in PBM from 21 pathological controls with other myopathies in whom mutations in DYSF were excluded and from 17 patients who had dysferlinopathy and two mutations in DYSF. Results were compared with protein expression in muscle by WB and immunohistochemistry (IH). We found a good correlation between skeletal muscle and monocytes using WB. However, IH results were misleading because abnormal expression of dysferlin was also observed in 13/21 pathological controls. The analysis of dysferlin protein expression in PBM is helpful when: 1) the skeletal muscle IH pattern is abnormal or 2) when muscle WB can not be performed either because muscle sample is lacking or insufficient or because the muscle biopsy is taken from a muscle at an end-stage and it mainly consists of fat and fibrotic tissue.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Patients' and physicians' perceptions and attitudes about oral anticoagulation and atrial fibrillation, a qualitative systematic review

  • Mas Dalmau, Gemma|||0000-0003-3720-0797
  • Sant Arderiu, E.
  • Enfedaque Montes, Belen|||0000-0002-2843-7250
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Pequeño Saco, S.
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Oral anticoagulant therapy reduces the risk of stroke in patients with atrial fibrillation, but many patients are still not prescribed this therapy. The causes of underuse of vitamin K antagonists oral anticoagulants are not clear but could be related, in part, to patients' and physicians' perceptions and attitudes towards the benefits and downsides of this treatment. The purpose of this systematic review was to evaluate and synthesize patients' and physicians' perceptions and attitudes towards the benefits and downsides of vitamin K antagonist, in order to explore potential factors related with its underuse. We included studies that used qualitative or mixed methods and focused on patients' and/or physicians' perceptions and attitudes towards oral anticoagulation. We systematically searched PubMed, EMBASE, ISI WoK, and PsycINFO from their inception until May 2013. Two reviewers independently assessed the quality of the included studies and synthesized results using a thematic analysis approach. We included a total of nine studies. In four studies, the quality assessed was excellent and in five was moderate. We identified three themes that were of interest to both physicians and patients: information to reinforce anticoagulation use, balance of benefits and downsides, roles in decision-making and therapy management. Three additional themes were of interest to patients: knowledge and understanding, impact on daily life, and satisfaction with therapy. The main difficulties with the use of anticoagulant treatment according to physicians were the perceived uncertainty, need of individualised decision-making, and the feeling of delegated responsibility as their main concerns. The main factors for patients were the lack of information and understanding. Physicians' and patients' perceptions and attitudes might be potential factors in the underuse of treatment with vitamin K antagonists. Improving the quality and usability of clinical guidelines, developing tools to help with the decision-making, enhancing coordination between primary care and hospital care, and improving information provided to patients could help improve the underuse of anticoagulation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cord blood DNA methylation reflects cord blood C-reactive protein levels but not maternal levels, a longitudinal study and meta-analysis

  • Yeung, Edwina H.
  • Guan, Weihua
  • Zeng, Xuehuo
  • Salas, Lucas A.
  • Mumford, Sunni L.
  • Prado Bert, Paula de|||0000-0003-1901-5846
  • Van Meel, Evelien R.
  • Malmberg, Anni
  • Sunyer, Jordi
  • Duijts, Liesbeth
  • Felix, Janine F.|||0000-0002-9801-5774
  • Czamara, Darina
  • Hämäläinen, Esa
  • Binder, Elisabeth B.
  • Raïkkönen, Katri|||0000-0003-3124-3470
  • Lahti, Jari|||0000-0002-4310-5297
  • London, Stephanie J.|||0000-0003-4911-5290
  • Silver, Robert M.
  • Schisterman, Enrique F.
Background: Prenatal inflammation has been proposed as an important mediating factor in several adverse pregnancy outcomes. C-reactive protein (CRP) is an inflammatory cytokine easily measured in blood. It has clinical value due to its reliability as a biomarker for systemic inflammation and can indicate cellular injury and disease severity. Elevated levels of CRP in adulthood are associated with alterations in DNA methylation. However, no studies have prospectively investigated the relationship between maternal CRP levels and newborn DNA methylation measured by microarray in cord blood with reasonable epigenome-wide coverage. Importantly, the timing of inflammation exposure during pregnancy may also result in different effects. Thus, our objective was to evaluate this prospective association of CRP levels measured during multiple periods of pregnancy and in cord blood at delivery which was available in one cohort (i.e., Effects of Aspirin in Gestation and Reproduction trial), and also to conduct a meta-analysis with available data at one point in pregnancy from three other cohorts from the Pregnancy And Childhood Epigenetics consortium (PACE). Secondarily, the impact of maternal randomization to low dose aspirin prior to pregnancy on methylation was assessed. Results: Maternal CRP levels were not associated with newborn DNA methylation regardless of gestational age of measurement (i.e., CRP at approximately 8, 20, and 36 weeks among 358 newborns in EAGeR). There also was no association in the meta-analyses (all p.